Proteome Systems brings several patented candidate markers to the partnership, while PHIMR contributes its technology in proteomics and reproductive biology, as well as its clinical expertise in ovarian cancer.
Proteome Systems brings several patented candidate markers to the partnership, while PHIMR contributes its technology in proteomics and reproductive biology, as well as its clinical expertise in ovarian cancer.